Novartis disputes U.S. senators’ report over Cohen contract

NBN Breaking News

NBN Breaking News

ZURICH (Reuters) – Novartis (NOVN.S) on Friday disputed a report from Democratic U.S. senators that concluded the Swiss drugmaker made misleading statements about its $1.2 million contract with a former attorney for President Donald Trump.

FILE PHOTO: Swiss drugmaker Novartis’ logo is seen at the company’s plant in the northern Swiss town of Stein, Switzerland October 23, 2017. REUTERS/Arnd Wiegmann/File Photo

“We disagree with the report’s conclusion that we issued a misleading public statement regarding the extent of our engagement with (Michael) Cohen,” Novartis said of the report compiled by staff of Sen. Ron Wyden, from Oregon, that concluded the company’s relationship with Cohen was longer and more detailed than it had previously disclosed.

Reporting by John Miller; Editing by Michael Shields

Source link


You may have missed